Primary cutaneous adenoid cystic carcinoma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Primary cutaneous adenoid cystic carcinoma
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Slow-growing skin nodule
Complications	Metastasis
Onset	Typically in adulthood
Duration	Chronic
Types	N/A
Causes	Unknown
Risks	Sun exposure, genetic predisposition
Diagnosis	Biopsy, histopathology
Differential diagnosis	Basal cell carcinoma, squamous cell carcinoma, trichoepithelioma
Prevention	N/A
Treatment	Surgical excision, radiation therapy
Medication	N/A
Prognosis	Generally good with treatment, but risk of recurrence
Frequency	Rare
Deaths	N/A

Primary cutaneous adenoid cystic carcinoma (PCACC) is a rare type of skin cancer that originates in the sweat glands. It is characterized by slow growth and a tendency to recur after treatment, but it is less likely to metastasize compared to other forms of adenoid cystic carcinoma that affect the salivary glands or other organs.

Symptoms

The most common presentation of PCACC is a small, firm, skin-colored or bluish nodule. These nodules are typically painless and can occur anywhere on the body, but they are most frequently found on the scalp, face, chest, and extremities. Due to their slow growth and non-specific appearance, PCACC lesions can often be mistaken for benign skin conditions.

Diagnosis

Diagnosis of PCACC involves a combination of clinical examination and histopathological analysis. A biopsy of the lesion is necessary to confirm the diagnosis. Histologically, PCACC is characterized by small, cystic spaces surrounded by basaloid cells in a tubular or cribriform pattern. Immunohistochemistry may also be used to differentiate PCACC from other types of skin cancer, with PCACC cells typically expressing markers such as CK7, CEA, and CD117.

Treatment

The primary treatment for PCACC is surgical excision with wide margins to reduce the risk of recurrence. In cases where complete surgical removal is not possible or if the cancer has recurred, radiation therapy may be considered as an adjunct treatment. There is limited evidence regarding the effectiveness of chemotherapy for PCACC, and it is generally not used unless the cancer has metastasized.

Prognosis

The prognosis for PCACC is generally favorable, with a low risk of metastasis. However, the recurrence rate is relatively high, necessitating long-term follow-up for patients. Early detection and complete surgical excision are critical for achieving the best outcomes.

Epidemiology

PCACC is a very rare condition, with only a few hundred cases reported in the medical literature. It can occur in individuals of any age but is most commonly diagnosed in adults between the ages of 50 and 70. There is no clear gender predilection.

Summary

Primary cutaneous adenoid cystic carcinoma is a rare and slow-growing form of skin cancer that arises from the sweat glands. Despite its low metastatic potential, the high rate of local recurrence underscores the importance of early diagnosis and aggressive surgical management. Ongoing research is needed to better understand the pathogenesis of PCACC and to develop more effective treatment strategies.

   This article is a medical stub. You can help WikiMD by expanding it!